Blueprint MedicinesBPMC 
$89.313.24%24h
3.24%24h
Global rank2611
Market cap$5.41B
Change 7d3.49%
YTD Performance-1.36%
SP500 benchmarkUnderperform
P/E-10.67
P/S21.69
Revenue$249.38M
Earnings-$506.98M
Dividend yield-
Main Sector
Healthcare
Blueprint Medicines BPMC Operating Margins
Operating Margin in 2022: -1.93%
According to Blueprint Medicines latest financial reports the company has an operating margin of -1.93%, an decrease of -25.39% to 2022. At the end of 2022 company had an operating margin of -2.59%.
Blueprint Medicines Operating Margin from 2020 to 2024
-
Value:-
BPMC Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -1.93% | -25.39% |
| 2022 | -2.59% | -26.44% |
| 2021 | -3.52% | -1005.47% |
| 2020 | 0.39% | - |
View the highest operating margin companies 
